Post
SHL Telemedicine’s at-home ECG device reduces hospital visits for patients
SHL Telemedicine has presented initial data from two clinical trials of its SmartHeart, showing a reduction in hospital visits in …
Florence Healthcare acquires clinical trial solutions provider VersaTrial
US-based clinical trial service provider Florence Healthcare has acquired VersaTrial in an effort to expedite research site enablement. The acquisition is …
Ascletis enrols all patients in trial of glioblastoma therapy
Chinese biotechnology company Ascletis Pharma has enrolled all 120 patients in its Phase III clinical trial of ASC40 in combination …
Anebulo outlines next steps for its cannabis intoxication antidote
Anebulo Therapeutics is preparing for further discussions with the US Food and Drug Administration (FDA) to finalise upcoming clinical trial …
NMD Pharma begins dosing patients in trial of SMA therapy
Danish biotechnology company NMD Pharma has dosed the first patient in a Phase II clinical trial of NMD670 to treat …
NMD Pharma begins dosing patients in trial of SMA therapy
Danish biotechnology company NMD Pharma has dosed the first patient in a Phase II clinical trial of NMD670 to treat …
Lantern Pharma doses first patient in solid tumour drug trial
US-based artificial intelligence (AI) company Lantern Pharma has dosed the first patient in a Phase I trial of its drug …
Promise for Relmada Therapeutics’s antidepressant REL-1017, but more data required
On 20 September, Relmada Therapeutics announced positive efficacy and safety data from a long-term, open-label, non-comparative, registrational Phase III trial …
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
Biopharma giant AbbVie has announced it intends to terminate its cancer drug deal with I-Mab, the creators of lemzoparlimab. The …
Novartis eyes first-line status for its radionucleotide therapy Lutathera
Novartis has announced that the Phase III NETTER-2 trial of the combination therapy of Lutathera (lutetium Lu 177 dotatate) and …
Biosergen and Alkem to launch BSG005 clinical studies in India
Biosergen and Alkem Laboratories have partnered to launch Phase II and Phase III clinical trials of the BSG005 drug for …
AffaMed receives China’s NMPA approval for CTA of Risuteganib
AffaMed Therapeutics has received approval from the China's National Medical Products Administration (NMPA) for its clinical trial application (CTA) of …
Dual primary endpoints met in Phase III trial of Padcev and Keytruda
Seagen and Astellas have reported that both primary endpoints have been met in their Phase III EV-302 trial of Padcev …
Island Pharmaceuticals to initiate study of ISLA-101 drug
Island Pharmaceuticals is set to initiate a single ascending dose study of ISLA-101 drug for the prevention and treatment of …
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Daiichi Sankyo has reported positive topline results from the Phase III TROPION-Breast01 clinical trial of datopotamab deruxtecan (Dato-DXd) for the …